People’s Republic of China

Vishal Jhanji

Vishal Jhanji is currently a Professor at the University of Pittsburgh School of Medicine and an Honorary Professor at the Chinese University of Hong Kong. Dr. Jhanji completed his Ophthalmology training at the prestigious All India Institute of Medical Sciences in New Delhi, India. He then completed specialist training in cornea, external eye diseases and refractive surgery in India and Melbourne, Australia. Professor Jhanji serves on the editorial board of the British Journal of Ophthalmology, Scientific Reports, Medicine, PLoS One, Asia Pacific Journal of Ophthalmology and Journal of Mobile Technology in Medicine. Dr. Jhanji is also a member of the Publications Committee for the Association for Research in Vision and Ophthalmology and International Meetings Committee for the American Academy of Ophthalmology.  Dr. Jhanji is a Visiting Professor at the Joint International Eye Center of Shantou University, China and the Wenzhou Medical School, China.  He has published over 200 papers in SCI international indexed peer-reviewed journals, authored 2 books and more than 15 book chapters.  His research interests include etiology, pathogenesis and treatment of dry eye, genetics, management and outcomes of keratoconus, corneal infection diagnosis and management, and corneal imaging and transplantation.
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members